The development of the vaccine with scientists at Oxford University -- and their decision to make it available at cost -- has made the Anglo-Swedish firm a household name. Since announcing successful clinical trials and having the vaccine passed by regulators, the company has faced a spate of challenges.from UK News Headlines, Latest UK News and Live Updates - Times of India https://ift.tt/2OIT7qg
No comments:
Post a Comment